Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples

ABSTRACT: Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples

PROVIDER: PRJNA727596 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14447348_1.fastq.gz	Fastqsanger.gz
	SRR14447348_2.fastq.gz	Fastqsanger.gz
	SRR14447349_1.fastq.gz	Fastqsanger.gz
	SRR14447349_2.fastq.gz	Fastqsanger.gz
	SRR14447350_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 158

Similar Datasets

Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples

Project description:Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples

| PRJNA727596 | ENA

Single Cell RNA sequencing (DropSeq) of esophageal adenocarcinoma and matched normal samples

Project description:Cancer grows within the complex ecosystem of the tumor microenvironment (TME) which can define responses to treatment. Esophageal adenocarcinoma (EAC) is typically resistant to cytotoxic therapies and immunotherapies have gained little traction against this disease. We used single cell RNA sequencing to identify the key constituents of the TME in EAC in a cohort of 22 patients. We found differences within and between individual patients in cancer cells and also in the stromal and immune cell populations. We found a subtype of cancer-associated fibroblasts, the myofibroblastic CAFs (myoCAFs), acting as TME interaction hubs to drive the hallmarks of cancer. Finally, we demonstrated the efficacy of repurposed PDE5 inhibitors in targeting myoCAFs in near-patient models of the disease.

2021-05-06 | GSE173950 | GEO

Esophageal Adenocarcinoma

Project description:Esophageal Adenocarcinoma

| PRJNA188928 | ENA

Esophageal adenocarcinoma

Project description:Esophageal adenocarcinoma

| PRJNA1072671 | ENA

Affymetrix SNP 6.0 data for analysis of esophageal adenocarcinoma samples

Project description:Esophageal adenocarcinoma is characterized by complex chromosomal alterations. Tumors were evaluated to identify regions of recurrent copy gains and losses and to determine the prognositic significance of the degree of segmental aneuploidy as measured by SNP array. 41 superficial esophageal adenocarcinomas were analyzed for copy number abnormalities. Matched normal lymph node tissue was used as a copy number reference.

2013-12-01 | E-GEOD-49396 | biostudies-arrayexpress

Lipidomics of esophageal adenocarcinoma

Project description:Lipidomics of esophageal adenocarcinoma

2021-08-22 | ST001942 | MetabolomicsWorkbench

Barrett's esophageal tissues and esophageal adenocarcinoma specimens

Project description:This SuperSeries is composed of the following subset Series: GSE37200: Gene expression profiling of Barrett’s esophageal tissues and esophageal adenocarcinoma specimens GSE37201: Gene expression profiling of esophageal adenocarcinoma Refer to individual Series

2012-04-10 | E-GEOD-37203 | biostudies-arrayexpress

Integrated analysis of genome-wide copy number and matched expression data reveals novel genes in esophageal adenocarcinoma

Project description:The incidence of esophageal and junctional adenocarcinoma has increased 6-fold in the west in the last 30 years and 5 year survival remains <14%. We aimed to characterize genome-wide aberrations in esophageal adenocarcinoma to further understand disease pathogenesis and ultimately identify groups with differential survivals with implications for clinical management. Oligo-array-based high-resolution analysis of copy number changes in 89 fresh frozen esophageal adenocarcinoma resection sections with long-term clinical follow-up data was performed. Good quality array comparative genomic hybridization profiles were obtained from 56/89 of the samples (63%). Our analyses confirmed known genomic aberrations in esophageal adenocarcinoma and identified 3 novel genomic regions with copy number changes. A modified T test with adjusted Bonferroni correction identified 17 genes with significantly different log2 ratios (p<4x10-7), including 6 novel genes, that characterize a group with a poorer survival. Total DNA isolated from human tissue sections was used to make fluorescently labeled DNA that was hybridized to Illumina HumanCytoSNP-12 Beadarray. All protocols were carried out following Illumina's standard protocols. After hybridization, raw data were recorded and normalized using Illumina's BeadStudio software v2.0. Matched expression data: GSE25201 GSE19417 D2 MRC/OEA0022CJ5 (GSM482819) D3 MRC/OEA0032CJ5 (GSM482817) D27 MRC/OEA0272CJ1 (GSM482814) D36 MRC/OEA0362CJ3 (GSM482806) D37 MRC/OEA0372AJ0 (GSM482800) D96 MRC/OEA0962BJ0 (GSM482847) D118 MRC/OEA1172CJ1 (GSM482848) D138 MRC/OEA1382CJ0 (GSM482844) D156 MRC/OEA1562CJ2 (GSM482853)

2011-05-09 | E-GEOD-25201 | biostudies-arrayexpress

Barrett's esophageal tissues and esophageal adenocarcinoma specimens

Project description:Barrett's esophageal tissues and esophageal adenocarcinoma specimens

| PRJNA158563 | ENA

Integrated analysis of genome-wide copy number and matched expression data reveals novel genes in esophageal adenocarcinoma

2011-05-09 | GSE25201 | GEO